Positive study results for Pain Therapeutics
May 12, 2015 at 13:03 PM EDT
Pain
Therapeutics Inc. (Nasdaq: PTIE) announced positive top-line results from a
Human Abuse Potential Study with REMOXY extended release capsules. The stock price leaped 89 cents to $2.83.
